Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial

Christopher C. Parker, Robert E. Coleman, Oliver Sartor, Nicholas J. Vogelzang, David Bottomley, Daniel Heinrich, Svein I. Helle, Joe M. O'Sullivan, Sophie D. Fosså, Aleš Chodacki, Paweł Wiechno, John Logue, Mihalj Seke, Anders Widmark, Dag Clement Johannessen, Peter Hoskin, Nicholas D. James, Arne Solberg, Isabel Syndikus, Jan Kliment, Steffen Wedel, Sibylle Boehmer, Marcos Dall’Oglio, Lars Franzén, Øyvind S. Bruland, Oana Petrenciuc, Karin Staudacher, Rui Li, Sten Nilsson

Open source

DOI: 10.1016/j.eururo.2017.06.021
Published: 2018-03
Container: European Urology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eururo.2017.06.021,
  title = {Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial},
  author = {Christopher C. Parker and Robert E. Coleman and Oliver Sartor and Nicholas J. Vogelzang and David Bottomley and Daniel Heinrich and Svein I. Helle and Joe M. O'Sullivan and Sophie D. Fosså and Aleš Chodacki and Paweł Wiechno and John Logue and Mihalj Seke and Anders Widmark and Dag Clement Johannessen and Peter Hoskin and Nicholas D. James and Arne Solberg and Isabel Syndikus and Jan Kliment and Steffen Wedel and Sibylle Boehmer and Marcos Dall’Oglio and Lars Franzén and Øyvind S. Bruland and Oana Petrenciuc and Karin Staudacher and Rui Li and Sten Nilsson},
  year = {2018},
  journal = {European Urology},
  doi = {10.1016/j.eururo.2017.06.021},
  url = {https://doi.org/10.1016/j.eururo.2017.06.021}
}

RIS

TY  - JOUR
TI  - Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial
AU  - Christopher C. Parker
AU  - Robert E. Coleman
AU  - Oliver Sartor
AU  - Nicholas J. Vogelzang
AU  - David Bottomley
AU  - Daniel Heinrich
AU  - Svein I. Helle
AU  - Joe M. O'Sullivan
AU  - Sophie D. Fosså
AU  - Aleš Chodacki
AU  - Paweł Wiechno
AU  - John Logue
AU  - Mihalj Seke
AU  - Anders Widmark
AU  - Dag Clement Johannessen
AU  - Peter Hoskin
AU  - Nicholas D. James
AU  - Arne Solberg
AU  - Isabel Syndikus
AU  - Jan Kliment
AU  - Steffen Wedel
AU  - Sibylle Boehmer
AU  - Marcos Dall’Oglio
AU  - Lars Franzén
AU  - Øyvind S. Bruland
AU  - Oana Petrenciuc
AU  - Karin Staudacher
AU  - Rui Li
AU  - Sten Nilsson
PY  - 2018
JO  - European Urology
DO  - 10.1016/j.eururo.2017.06.021
UR  - https://doi.org/10.1016/j.eururo.2017.06.021
ER  -

APA

Parker, C. C., Coleman, R. E., Sartor, O., Vogelzang, N. J., Bottomley, D., Heinrich, D., Helle, S. I., O'Sullivan, J. M., Fosså, S. D., Chodacki, A., Wiechno, P., Logue, J., Seke, M., Widmark, A., Johannessen, D. C., Hoskin, P., James, N. D., Solberg, A., Syndikus, I., Kliment, J., Wedel, S., Boehmer, S., Dall’Oglio, M., Franzén, L., Bruland, Ø. S., Petrenciuc, O., Staudacher, K., Li, R., & Nilsson, S. (2018). Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial. European Urology. https://doi.org/10.1016/j.eururo.2017.06.021

Source records

crossref · retrieved 2026-09-27T11:59:25.044Z